// App-Quantinova.ai

5015 : Pretreatment carcinoembryonic antigen levels predict survival in patients with rectal adenocarcinoma

Researchers

Presenter

  • Oxana V. Makarova-Rusher

Principal Investigators

  • Julius Strauss

  • Susanna Ulahannan

  • Chul Kim

  • Jaydira Del Rivero

  • Austin Duffy

  • Tim F. Greten

Medical Centers

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Carcinoembryonic antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved